En Es
Categories

BioFire Diagnostics

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based on a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. Its specialties include infectious disease diagnostics, multiplex PCR, real-tim ...
Gold member
Products Covid-19Summary
Close

Covid-19 BioFire Diagnostics

Clinical Laboratory

Respiratory Panel
BioFire® Respiratory 2.1 (RP2.1) Panel (EUA)

The BioFire RP2.1 Panel (EUA) uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Fast and comprehensive, the BioFire RP2.1 Panel (EUA) offers a run time of about 45 minutes, enabling high efficiency and throughput on the BioFire® FilmArray® 2.0 and the BioFire® FilmArray® Torch Systems. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients. Quick turnaround on a broad menu of pathogens may also help clinicians make vital decisions regarding admission, isolation, cohorting, and additional diagnostic testing.
More details

Respiratory Panel with SARS-CoV-2
BioFire Respiratory 2.1-EZ (RP2.1- EZ) Panel With SARS-CoV-2

The BioFire RP2.1-EZ Panel is authorized by the FDA through an Emergency Use Authorization and uses a syndromic approach to accurately detect and identify a wide range of pathogens—including SARS-CoV-2. The panel identifies a menu of 19 respiratory targets in one multiplex PCR test, with results in about 45 minutes. The BioFire RP2.1-EZ Panel is designed to run on the CLIA-waived BioFire® FilmArray® 2.0 EZ Configuration System.
More details
Close

About BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based on a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. Its specialties include infectious disease diagnostics, multiplex PCR, real-time PCR instruments and reagents, hi-res melting instruments and kits, molecular diagnostics, and syndromic testing.

Recently updated

Respiratory Panel with SARS-CoV-2
BioFire Respiratory 2.1-EZ (RP2.1- EZ) Panel With SARS-CoV-2

The BioFire RP2.1-EZ Panel is authorized by the FDA through an Emergency Use Authorization and uses a syndromic approach to accurately detect and identify a wide range of pathogens—including SARS-CoV-2. The panel identifies a menu of 19 respiratory targets in one multiplex PCR test, with results in about 45 minutes. The BioFire RP2.1-EZ Panel is designed to run on the CLIA-waived BioFire® FilmArray® 2.0 EZ Configuration System.
More details

Respiratory Panel
BioFire® Respiratory 2.1 (RP2.1) Panel (EUA)

The BioFire RP2.1 Panel (EUA) uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Fast and comprehensive, the BioFire RP2.1 Panel (EUA) offers a run time of about 45 minutes, enabling high efficiency and throughput on the BioFire® FilmArray® 2.0 and the BioFire® FilmArray® Torch Systems. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients. Quick turnaround on a broad menu of pathogens may also help clinicians make vital decisions regarding admission, isolation, cohorting, and additional diagnostic testing.
More details

Molecular Testing System
FilmArray EZ

The FilmArray EZ is a CLIA-waived system for near patient molecular testing that enables decentralized molecular testing throughout a provider network. Designed for use with Respiratory Panel (RP) EZ, it offers an intuitive and simplified user interface and results report.
More details

Clinical Laboratory

Respiratory Panel with SARS-CoV-2
BioFire Respiratory 2.1-EZ (RP2.1- EZ) Panel With SARS-CoV-2

The BioFire RP2.1-EZ Panel is authorized by the FDA through an Emergency Use Authorization and uses a syndromic approach to accurately detect and identify a wide range of pathogens—including SARS-CoV-2. The panel identifies a menu of 19 respiratory targets in one multiplex PCR test, with results in about 45 minutes. The BioFire RP2.1-EZ Panel is designed to run on the CLIA-waived BioFire® FilmArray® 2.0 EZ Configuration System.
More details

Respiratory Panel
BioFire® Respiratory 2.1 (RP2.1) Panel (EUA)

The BioFire RP2.1 Panel (EUA) uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Fast and comprehensive, the BioFire RP2.1 Panel (EUA) offers a run time of about 45 minutes, enabling high efficiency and throughput on the BioFire® FilmArray® 2.0 and the BioFire® FilmArray® Torch Systems. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients. Quick turnaround on a broad menu of pathogens may also help clinicians make vital decisions regarding admission, isolation, cohorting, and additional diagnostic testing.
More details

Molecular Testing System
FilmArray EZ

The FilmArray EZ is a CLIA-waived system for near patient molecular testing that enables decentralized molecular testing throughout a provider network. Designed for use with Respiratory Panel (RP) EZ, it offers an intuitive and simplified user interface and results report.
More details

Molecular Diagnostic Testing System
BioFire® FilmArray® 2.0 System

The FilmArray 2.0 is a molecular diagnostic testing system with single database management of up to eight instruments per computer and capability to test up to 175 samples a day. Its LIS-interfacing capabilities enable simplified test ordering and send outs, quicker turnaround times and increased accuracy by minimizing manual data entry.
More details

Random Access System
BioFire® FilmArray® Torch System

Providing up to six times more sample throughput per square foot of benchtop space, the high throughput BioFire® FilmArray® Torch is a fully integrated, random and continuous access system designed to meet your laboratory’s syndromic infectious disease testing needs. The BioFire Torch is compatible with all existing BioFire® FilmArray® Panels providing the quick, comprehensive, and accurate results you’ve come to expect from BioFire Diagnostics.
More details

Meningitis/Encephalitis (ME) Panel
BioFire® FilmArray® Meningitis/Encephalitis (ME) Panel

The BioFire ME Panel tests for a comprehensive set of 14 bacteria, viruses, and yeast. The BioFire ME Panel identifies the most common viral, bacterial, and yeast pathogens that cause infections in the central nervous system, which in some cases can be life-threatening.
More details

Rapid Diagnostic Test
BioFire® FilmArray® Blood Culture Identification Panels

The newly expanded and FDA-cleared BioFire® Blood Culture Identification 2 (BCID2) Panel tests for 43 targets associated with bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes—all with one test and with results available in about an hour from positive blood culture. The panel features broadened inclusivity for Enterobacterales, new assays for fungal and anaerobic pathogens, and additional identification of coagulase-negative Staphylococcus species. The panel menu includes seven additional resistance genes, including carbapenemases and colistin resistance genes.
More details

Rapid Diagnostic Test
BioFire® FilmArray® Gastrointestinal (GI) Panel

The FilmArray Gastrointestinal (GI) Panel tests stool specimens for a comprehensive set of 22 common pathogens associated with gastroenteritis. Designed with the syndromic approach in mind, the panel combines a broad grouping of probable pathogenic causes into a single, rapid test.
More details

Laboratory Software
BioFire® FilmArray® Link Software

The FilmArray Link Software allows the FilmArray System to interface with an LIS, allowing test results to be electronically transferred. The LIS-interfacing capabilities enable faster turnaround and increased accuracy, while the software optimizes workflow and ensures efficient data management. BioFire Link is capable of directly connecting the BioFire® FilmArray® 2.0 and Torch Systems with several LISs, including Cerner, MEDITECH, Sunquest, Orchard, Soft, IBM Merge, CyberLab, LabDaq, and more. BioFire is also able to connect with many LISs via a middleware connection, such as Data Innovations® Instrument Manager or McKesson® Lab SD2.
More details
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions